[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines].
Misu, Hirofumi
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines]. [electronic resource] - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine Jan 2016 - 25-30 p. digital
Publication Type: Journal Article
0021-5384
10.2169/naika.105.25 doi
Diabetes Mellitus, Type 2--etiology
Humans
Insulin Resistance
Intercellular Signaling Peptides and Proteins--metabolism
Neovascularization, Pathologic
Non-alcoholic Fatty Liver Disease--complications
Selenoprotein P--metabolism
alpha-2-HS-Glycoprotein--metabolism
[Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: III. Relation with Type II diabetes: regulation by hepatokines]. [electronic resource] - Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine Jan 2016 - 25-30 p. digital
Publication Type: Journal Article
0021-5384
10.2169/naika.105.25 doi
Diabetes Mellitus, Type 2--etiology
Humans
Insulin Resistance
Intercellular Signaling Peptides and Proteins--metabolism
Neovascularization, Pathologic
Non-alcoholic Fatty Liver Disease--complications
Selenoprotein P--metabolism
alpha-2-HS-Glycoprotein--metabolism